Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma.
Perez-Lanzon M, Carbonnier V, Cordier P, De Palma FDE, Petrazzuolo A, Klein C, Arbaretaz F, Mangane K, Stoll G, Martins I, Fohrer Ting H, Paillet J, Mouillet-Richard S, Le Corre D, Xiao W, Sroussi M, Desdouets C, Laurent-Puig P, Pol J, Lopez-Otin C, Maiuri MC, Kroemer G. Perez-Lanzon M, et al. J Immunother Cancer. 2023 Jun;11(6):e007117. doi: 10.1136/jitc-2023-007117. J Immunother Cancer. 2023. PMID: 37344100 Free PMC article.
Organoids for Modeling Genetic Diseases.
Perez-Lanzon M, Kroemer G, Maiuri MC. Perez-Lanzon M, et al. Int Rev Cell Mol Biol. 2018;337:49-81. doi: 10.1016/bs.ircmb.2017.12.006. Epub 2018 Feb 12. Int Rev Cell Mol Biol. 2018. PMID: 29551162 Review.
Failure of immunosurveillance accelerates aging.
Perez-Lanzon M, Zitvogel L, Kroemer G. Perez-Lanzon M, et al. Oncoimmunology. 2019 Feb 9;8(4):e1575117. doi: 10.1080/2162402X.2019.1575117. eCollection 2019. Oncoimmunology. 2019. PMID: 30906669 Free PMC article.
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, Enot D, Hensler M, Kremer M, Stoll G, Hu Y, Massa C, Formenti SC, Seliger B, Elemento O, Spisek R, André F, Zitvogel L, Delaloge S, Kroemer G, Galluzzi L. Buqué A, et al. Nat Commun. 2020 Jul 30;11(1):3819. doi: 10.1038/s41467-020-17644-0. Nat Commun. 2020. PMID: 32732875 Free PMC article.
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, Enot D, Hensler M, Kremer M, Stoll G, Hu Y, Massa C, Formenti SC, Seliger B, Elemento O, Spisek R, André F, Zitvogel L, Delaloge S, Kroemer G, Galluzzi L. Buqué A, et al. Nat Commun. 2020 Sep 17;11(1):4787. doi: 10.1038/s41467-020-18719-8. Nat Commun. 2020. PMID: 32943636 Free PMC article.
MPA/DMBA-driven mammary carcinomas.
Buqué A, Perez-Lanzón M, Petroni G, Humeau J, Bloy N, Yamazaki T, Sato A, Kroemer G, Galluzzi L. Buqué A, et al. Methods Cell Biol. 2021;163:1-19. doi: 10.1016/bs.mcb.2020.08.003. Epub 2020 Oct 1. Methods Cell Biol. 2021. PMID: 33785159
23 results